(Bloomberg) -- Amgen Inc. is considering a bid for Medivation Inc., joining a group of suitors circling the cancer therapy company, according to people with knowledge of the matter.
Amgen is speaking with advisers as it evaluates whether to make an offer, …
No comments:
Post a Comment